HEAT BIOLOGICS
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) adjuvant technology for use in a number of oncology and infectious disease indications. Heat’s ImPACT therapy is a first-in-class fully human adjuvant system that functions as both an immune stimulator and an antigen-delivery system. ImPACT is rapidly applied to a selected off-the-shelf cancer cell line to effectively transform living tumor into powerful machines... that “pump out” their full antigenic fingerprint to robustly stimulate the immune system against the targeted disease. ImPACT is applicable to a wide range of cancers as well as infectious diseases including HIV, HCV and malaria. Heat is currently in Phase II clinical trials with its first drug to treat Non Small Cell Lung Cancer (NSCLC) and plans to initiate clinical trials against additional cancers in 2012.
HEAT BIOLOGICS
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.heatbio.com
Total Employee:
11+
Status:
Active
Contact:
9192407540
Email Addresses:
[email protected]
Total Funding:
50.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
AccuTheranostics
AccuTheranostics is a biotechnology company focused on the business of individualizing chemotherapy for cancer patients.
Arima Genomics
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-21 | Elusys Therapeutics | Elusys Therapeutics acquired by Heat Biologics | N/A |
Investors List
Square 1 Bank
Square 1 Bank investment in Post-IPO Debt - Heat Biologics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-06 | Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy |
Official Site Inspections
http://www.heatbio.com Semrush global rank: 4 M Semrush visits lastest month: 3.1 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Heat Biologics"
www.heatbio.com
Www.heatbio.comSee details»
NightHawk Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 9192407540 Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic …See details»
Heat Biologics Completes Name Change to NightHawk …
DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. / NightHawk Biosciences (NYSE American: HTBX; NHWK), a fully integrated biopharmaceutical company …See details»
Heat Biologics Announces Planned Name Change to NightHawk
DURHAM, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing novel …See details»
Heat Biologics Completes Name Change to NightHawk …
DURHAM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. / NightHawk Biosciences (NYSE American: HTBX; NHWK), a fully integrated biopharmaceutical company …See details»
Heat Biologics - VentureRadar
"Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune …See details»
Heat Biologics - Overview, News & Similar companies - ZoomInfo
May 3, 2022 Heat Biologics contact info: Phone number: (919) 240-7133 Website: www.heatbio.com What does Heat Biologics do? Heat Biologics, Inc., a biopharmaceutical …See details»
Heat Biologics Information - RocketReach
Heatbio.com; 2 775527XXXX; 919684XXXX; Walid Kara Clinical Research Associate at Heat Biologics Pensacola, Florida, United States View. 5 850377XXXX; 850982XXXX; …See details»
Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing …
Mar 25, 2022 For more information, please visit: www.heatbio.com, and also follow us on ... the capabilities helping position Scorpion as a leading contract development and manufacturing …See details»
Heat Biologics to Provide Corporate Update
Aug 30, 2021 Conference call scheduled for September 2nd at 11:00 AM ET. DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a …See details»
Heat Biologics to Provide Corporate Update - GlobeNewswire
DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class …See details»
Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing …
Mar 25, 2022 Heat Biologics. New 3-D process designed to increase yield and improve operating efficiency for rapid and scalable manufacturing of HS-110, gp-96 based cell …See details»
Heat Biologics’ Announces Planned Investor and Media Livestream …
Apr 14, 2022 For more information, please visit: www.heatbio.com, and also follow us on Twitter. Media and Investor Relations Contact David Waldman +1 919 289 4017 …See details»
Heat Biologics to Provide Corporate Update - Yahoo Finance
Aug 30, 2021 For more information, please visit: www.heatbio.com, and also follow us on Twitter. Media and Investor Relations Contact David Waldman +1 919 289 4017 …See details»
Heat Biologics Unveils Enhanced Allogeneic Cell ... - BioSpace
Mar 25, 2022 For more information, please visit: www.heatbio.com, and also follow us on Twitter. ... the capabilities helping position Scorpion as a leading contract development and …See details»
Heat Biologics’ Announces Planned Investor and Media Livestream …
DURHAM, N.C., April 14, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in …See details»
Heat Biologics’ Announces Planned Investor and Media
DURHAM, N.C., April 14, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in …See details»
Heat Biologics Unveils Enhanced Allogeneic Cell - GlobeNewswire
Mar 25, 2022 For more information, please visit: www.heatbio.com, ... the capabilities helping position Scorpion as a leading contract development and manufacturing organization (CDMO), …See details»
Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine …
DURHAM, N.C., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class …See details»